Logo image of CETX

CEMTREX INC (CETX) Stock Fundamental Analysis

NASDAQ:CETX - Nasdaq - US15130G8814 - Common Stock - Currency: USD

1.25  -0.07 (-5.3%)

After market: 1.27 +0.02 (+1.6%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CETX. CETX was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. CETX has a bad profitability rating. Also its financial health evaluation is rather negative. CETX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CETX has reported negative net income.
In the past year CETX had a positive cash flow from operations.
CETX had negative earnings in each of the past 5 years.
CETX had a negative operating cash flow in each of the past 5 years.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -53.90%, CETX is doing worse than 87.20% of the companies in the same industry.
With a Return On Equity value of -389.20%, CETX is not doing good in the industry: 97.60% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -53.9%
ROE -389.2%
ROIC N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

With a decent Gross Margin value of 42.43%, CETX is doing good in the industry, outperforming 73.60% of the companies in the same industry.
In the last couple of years the Gross Margin of CETX has remained more or less at the same level.
CETX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

CETX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CETX has less shares outstanding
Compared to 5 years ago, CETX has less shares outstanding
Compared to 1 year ago, CETX has an improved debt to assets ratio.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -1.03, we must say that CETX is in the distress zone and has some risk of bankruptcy.
CETX has a worse Altman-Z score (-1.03) than 84.00% of its industry peers.
A Debt/Equity ratio of 1.48 is on the high side and indicates that CETX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.48, CETX is doing worse than 94.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC5.07%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.21 indicates that CETX should not have too much problems paying its short term obligations.
The Current ratio of CETX (1.21) is worse than 88.00% of its industry peers.
A Quick Ratio of 0.95 indicates that CETX may have some problems paying its short term obligations.
The Quick ratio of CETX (0.95) is worse than 83.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.95
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CETX have decreased strongly by -564.41% in the last year.
CETX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.93%.
The Revenue has been growing by 11.21% on average over the past years. This is quite good.
EPS 1Y (TTM)-564.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.42%
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%58.8%

3.2 Future

The Earnings Per Share is expected to grow by 89.28% on average over the next years. This is a very strong growth
CETX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.00% yearly.
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 100K -100K 200K -200K 300K

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 0.61, the valuation of CETX can be described as very cheap.
Based on the Price/Forward Earnings ratio, CETX is valued cheaply inside the industry as 99.20% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 37.54. CETX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.61
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CETX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.89
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CETX's earnings are expected to grow with 89.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEMTREX INC

NASDAQ:CETX (7/24/2025, 8:00:00 PM)

After market: 1.27 +0.02 (+1.6%)

1.25

-0.07 (-5.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-12 2025-05-12
Earnings (Next)08-12 2025-08-12
Inst Owners9.77%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap4.03M
Analysts82.86
Price TargetN/A
Short Float %23.66%
Short Ratio0.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.61
P/S 0.05
P/FCF N/A
P/OCF 9.98
P/B 0.63
P/tB 1.49
EV/EBITDA 31.89
EPS(TTM)-610.99
EYN/A
EPS(NY)2.05
Fwd EY164.02%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)0.13
OCFY10.02%
SpS22.92
BVpS1.99
TBVpS0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.9%
ROE -389.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.43%
FCFM N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
F-Score5
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF N/A
Debt/EBITDA 14.16
Cap/Depr 176.61%
Cap/Sales 3.12%
Interest Coverage N/A
Cash Conversion 60.18%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.95
Altman-Z -1.03
F-Score5
WACC5.07%
ROIC/WACCN/A
Cap/Depr(3y)155.23%
Cap/Depr(5y)125.9%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-564.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.42%
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%58.8%
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.5%
OCF growth 3YN/A
OCF growth 5YN/A